BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.39 CNY | +2.59% |
|
+0.27% | -5.29% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 6.84B 947M | Sales 2025 * | 8.23B 1.14B | Capitalization | 30.34B 4.2B |
|---|---|---|---|---|---|
| Net income 2024 * | 847M 117M | Net income 2025 * | 1.13B 157M | EV / Sales 2024 * | 4.25 x |
| Net cash position 2024 * | 1.27B 176M | Net cash position 2025 * | 1.48B 206M | EV / Sales 2025 * | 3.51 x |
| P/E ratio 2024 * |
36
x | P/E ratio 2025 * |
27
x | Employees | 4,655 |
| Yield 2024 * |
0.81% | Yield 2025 * |
1.06% | Free-Float | 29.33% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +2.59% | ||
| 1 week | +0.27% | ||
| Current month | +3.07% | ||
| 1 month | +18.24% | ||
| 3 months | +1.95% | ||
| 6 months | -16.76% | ||
| Current year | -5.29% |
1 week
61.01
63.45
1 month
53.1965.32
Current year
50.2269.48
1 year
50.2299.49
3 years
50.22314.99
5 years
50.22314.99
10 years
50.22314.99
| Managers | Title | Age | Since |
|---|---|---|---|
Yan Zhao
CEO | Chief Executive Officer | 57 | 02-12-31 |
Yi Zheng Luan
DFI | Director of Finance/CFO | 39 | 19-12-12 |
Xue Ping Guo
CTO | Chief Tech/Sci/R&D Officer | 59 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jia Jun Guo
BRD | Director/Board Member | 49 | 18-03-31 |
Ai Hua Liu
PRN | Corporate Officer/Principal | 61 | 16-12-31 |
Guan Ting Chen
BRD | Director/Board Member | 61 | 22-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.84% | 1 M€ | -10.73% | - | |
| 1.36% | 45 M€ | -13.72% | - | |
| 1.36% | 45 M€ | -12.49% | - | |
| 1.36% | 38 M€ | -12.52% | - | |
| 0.74% | 2 M€ | -12.23% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 63.39 | +2.59% | 2,252,887 |
| 24-05-16 | 61.79 | -0.48% | 1,223,301 |
| 24-05-15 | 62.09 | -0.86% | 1,505,170 |
| 24-05-14 | 62.63 | +0.69% | 1,879,787 |
| 24-05-13 | 62.2 | -0.16% | 1,938,233 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes
Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
63.39
CNY
Average target price
72.07
CNY
Spread / Average Target
+13.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.29% | 4.1B | |
| -2.32% | 92.59B | |
| +3.68% | 41.43B | |
| -10.90% | 33.49B | |
| -19.56% | 14.62B | |
| -9.06% | 12.77B | |
| -11.34% | 11.58B | |
| -43.53% | 11.35B | |
| +3.75% | 8.97B | |
| -6.32% | 8.3B |
- Stock Market
- Equities
- 688363 Stock
